Cargando…
Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
PURPOSE: Circulating tumor DNA (ctDNA) has been used for disease monitoring in several types of cancer. The aim of our study was to investigate whether ctDNA can be used for response monitoring in neuroblastoma. METHODS: One hundred forty-nine plasma samples from 56 patients were analyzed by quantit...
Autores principales: | van Zogchel, Lieke M. J., van Wezel, Esther M., van Wijk, Jalenka, Stutterheim, Janine, Bruins, Wassilis S. C., Zappeij-Kannegieter, Lily, Slager, Tirza J. E., Schumacher-Kuckelkorn, Roswitha, Verly, Iedan R. N., van der Schoot, C. Ellen, Tytgat, Godelieve A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446415/ https://www.ncbi.nlm.nih.gov/pubmed/32923888 http://dx.doi.org/10.1200/PO.19.00261 |
Ejemplares similares
-
Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors
por: van Zogchel, Lieke M. J., et al.
Publicado: (2021) -
Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR
por: van Zogchel, Lieke M. J., et al.
Publicado: (2021) -
Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
por: Lak, Nathalie S.M., et al.
Publicado: (2021) -
Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
por: Lobo, João, et al.
Publicado: (2021) -
Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential
por: Lak, Nathalie S. M., et al.
Publicado: (2023)